Elizabeth A. Cairns
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The Acute Effects of Non-concussive Head Impacts on Brain Microstructure, Chemistry and Function in Male Soccer Players: A Pilot Randomised Controlled Trial.
Journal: Sports medicine - open
Published: July 23, 2024
Structure-Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA.
Journal: ACS chemical neuroscience
Published: May 20, 2024
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA.
Journal: ACS chemical neuroscience
Published: April 10, 2024
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA.
Journal: RSC medicinal chemistry
Published: December 30, 2023
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing.
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing.
Journal: Frontiers in pharmacology
Published: January 12, 2023
Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA.
Journal: ACS chemical neuroscience
Published: December 19, 2022
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
Journal: Frontiers in psychiatry
Published: September 20, 2022
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs.
Journal: Frontiers in psychiatry
Published: August 03, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.
Journal: ACS chemical neuroscience
Published: April 20, 2022
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years.
Journal: Frontiers in pharmacology
Published: March 01, 2022
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
Journal: ACS chemical neuroscience
Published: October 22, 2021
Last Updated: 09/26/2026